HBIO

시간 외 거래: 6.17 0.045 +0.73%

Harvard Bioscience Inc (HBIO)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1096)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

최신 SEC 제출 서류

HBIO's Discussions on Twitter

Compare HBIO vs ISRG, BDX, MDLN, ALC, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HBIO Harvard Bioscience Inc	6.125	27.24M	85.53M	-9.78M	1.28M	-2.1952
ISRG Intuitive Surgical Inc	405.97	143.33B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	155.19	42.96B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	39.61	32.87B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	67.61	33.07B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	198.43	29.05B	5.54B	1.52B	1.74B	10.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-04-09	다운그레이드	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	업그레이드	The Benchmark Company	Speculative Buy → Buy
2021-01-07	업그레이드	The Benchmark Company	Speculative Buy → Buy
2020-12-09	개시	Northland Capital	Outperform
2020-11-10	개시	KeyBanc Capital Markets	Overweight
2019-07-08	다운그레이드	Janney	Buy → Neutral
2018-01-24	재확인	Janney	Buy
2018-01-23	재확인	The Benchmark Company	Buy
2016-11-17	개시	Singular Research	Buy
2015-07-28	개시	The Benchmark Company	Buy

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience Inc (HBIO) 재무 분석

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Compare HBIO vs ISRG, BDX, MDLN, ALC, RMD

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience, Inc. Actuals & Estimates (NASDAQ:HBIO) - TradingView

HBIO Forecast — Price Target — Prediction for 2027 - TradingView

Price to sales forward of Harvard Bioscience, Inc. – NASDAQ:HBIO - TradingView

Price to book forward of Harvard Bioscience, Inc. – NASDAQ:HBIO - TradingView

Harvard Bioscience Inc (HBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Harvard Bioscience Inc (HBIO) Institutional Confidence - TradingKey

Harvard Bioscience Inc (HBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey

Harvard Bioscience Inc (HBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Harvard Bioscience holds key trading range, shares between support and resistance - AD HOC NEWS

HBIO News | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill

Harvard Bioscience Inc (HBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Harvard Bioscience Inc (HBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Harvard Bioscience Inc (HBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Harvard Bioscience Inc (HBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Harvard Bioscience Inc (HBIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Director at Harvard Bioscience (HBIO) granted 16,556 restricted stock units - Stock Titan

Harvard Bioscience (HBIO) director awarded 16,556 restricted stock units - Stock Titan

Harvard Bioscience (NASDAQ: HBIO) awards director 16,556 RSUs - Stock Titan

Harvard Bioscience (HBIO) director awarded 16,556 RSUs in new grant - Stock Titan

Director at Harvard Bioscience (HBIO) awarded 16,556 RSUs - Stock Titan

HBIO Stock Price, Quote & Chart - ChartMill

Harvard Bioscience | 8-K: Harvard Bioscience Announces First Quarter 2026 Financial Results - Moomoo

Harvard Bioscience Shareholders Expand Equity Plans, Elect Directors - TipRanks

Harvard Bioscience (NASDAQ: HBIO) shareholders approve equity and ESPP share increases - Stock Titan

Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN

Earnings call transcript: Harvard Bioscience Q1 2026 misses EPS forecast, stock drops - Investing.com Nigeria

Harvard Bioscience: HBIO stock stalls, margin pressure in focus - Bez Kabli

HBIO PE Ratio & Valuation, Is HBIO Overvalued - Intellectia AI

HBIO Q1 2026 Earnings: EPS Surprises to the Upside Despite Challenging QuarterEstimate Dispersion - thelegaladvocate.com

Harvard Bioscience Slips as Traders Assess Support Levels; HBIO Down Nearly 3%Open Trading Community - Newser

Harvard Bioscience (HBIO) Q1 2026 Earnings Beat: Revenue $N/A, EPS $-0.33Real Trader Insights - Newser

Harvard Bioscience stock (US4169061052): Q2 2025 mixed results still define the story - AD HOC NEWS

Harvard Bioscience, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-05-15 - Seeking Alpha

Earnings call transcript: Harvard Bioscience misses Q1 2026 forecasts - Investing.com UK

Earnings call transcript: Harvard Bioscience misses Q1 2026 forecasts By Investing.com - Investing.com Australia

Harvard Bioscience (HBIO) insider entity reports 293,676 shares, 6.5% stake - Stock Titan

Harvard Bioscience Transitions to Translational Science Focus in 2026 - HarianBasis.co

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2026 Earnings Call Transcript - Insider Monkey

Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New Product Innovations - GuruFocus

Harvard Bioscience Q1 2026 slides: margins rise amid revenue miss By Investing.com - Investing.com Nigeria

Harvard Bioscience Q1 2026 Earnings Call Transcript - MarketBeat

HBIO Maintains Positive Outlook for FY26 Financial Performance - GuruFocus

Harvard Bioscience (HBIO) Reports Q1 Earnings and Reaffirms 2026 Revenue Guidance - GuruFocus

Discontinued operations of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView

Harvard Bioscience Reaffirms Full-Year 2026 Financial Guidance >HBIO - Moomoo

Harvard Bioscience: Consolidation of Manufacturing Operations Progressing on Schedule >HBIO - Moomoo

Harvard Bioscience (NASDAQ: HBIO) posts Q1 2026 loss as debt costs rise - Stock Titan

Harvard Bioscience, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

HBIO Forecasts Q2 Margins and Revenue Growth - GuruFocus

Harvard Bioscience Inc (HBIO) 재무 분석

매출

순이익

현금흐름

주당 순 이익

HBIO과 유사한 종목